Allogeneic Stem Cell Transplant Overview

 

High-dose chemotherapy and allogeneic bone marrow or blood stem cell transplantation is a treatment strategy that uses the administration of high doses of anticancer drugs and/or radiation therapy for the purpose of killing cancer cells and transplantation of stem cells to "rescue" or restore bone marrow blood and immune cell production. Transplantation is the term for transfer of tissue (a graft) from one person to another. Allogeneic is the term for a tissue graft from one person to another.

There are many types of allogeneic grafts that can be transplanted from one person to another, including skin, heart, kidney, liver, etc. However, the easiest organ in the body to transplant is the bone marrow. This is because a small quantity of stem cells taken from the bone marrow or peripheral blood of one person can repopulate the entire bone marrow organ of another person. In contrast to other types of transplants, the donor does not "miss" the small amount of bone marrow stem cells removed. A small quantity of bone marrow contains stem cells that are capable of dividing rapidly and repopulating the entire blood and immune system of another person within a short period of time.

High-dose chemotherapy and allogeneic stem cell transplantation is a component of an overall treatment strategy used to treat many kinds of cancer. High-dose chemotherapy and allogeneic stem cell transplantation may be appropriately used as the initial or subsequent treatment, depending on the type of cancer. It is not a treatment of last resort. The role of stem cell transplantation in the management of a specific cancer should be carefully planned following an initial diagnosis of cancer. To learn more about allogeneic stem cell transplantation and the role it may play in the treatment of your cancer, select one of the following.

This content was last modified on May 23, 2006 .
Latest Cancer News
Psychological Intervention May Improve Survival in Breast Cancer

November 19, 2008 — Breast cancer patients who receive psychological intervention during treatment experience improved overall survival, as well as a reduced risk of cancer recurrence, according to the results of a study published in an early online issue of Cancer.

High-dose Chemotherapy with Cerubidine® Significantly Prolongs Survival in Acute Myeloid Leukemia

November 19, 2008 — Patients with acute myeloid leukemia (AML) who receive high doses of Cerubidine® (daunorubicin) live significantly longer than patients who receive a standard dose of the same drug, according to preliminary results of a large, randomized clinical trial sponsored by the National Cancer Institute and conducted by the Eastern Cooperative Oncology Group (ECOG).

Gender and age impact stomach cancer prognosis

November 19, 2008 — NEW YORK (Reuters Health) - Older men and younger women fare worse with stomach, or "gastric" cancer than patients in other gender and age groups, research shows.

Select news items provided by Reuters Health